Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-18T03:47:07.700Z Has data issue: false hasContentIssue false

Normothymotics, “Mood-Normalizers”

Are Lithium and the Imipramine Drugs Specific for Affective Disorders?

Published online by Cambridge University Press:  29 January 2018

Mogens Schou*
Affiliation:
Neurochemical and Psychopharmacological Research Unit, Institute of Psychiatry, Risskov, Denmark
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

The action of almost all drugs used so far in psychiatric pharmacotherapy has been directed against psychopathological symptoms or syndromes and not against mental diseases as such, the nosological entities defined by classical clinical psychiatry. In this paper the attention will be drawn towards a different type of drug: compounds with an action specific to a disease rather than to a symptom, and evidence will be presented for the existence within this class of a group that is characterized by being active against affective disorders (manic-depressive psychosis). Normothymotics, “mood-normalizers”, is proposed as a collective name for drugs belonging to this group.

Information

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1963 

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.